[Antineoplastic effect of 5-fluorocytosine and cytosine deaminase on brain tumor (author's transl)]. 1982

T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai

UI MeSH Term Description Entries
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005437 Flucytosine A fluorinated cytosine analog that is used as an antifungal agent. 5-Fluorocytosine,Alcobon,Ancobon,Ancotil
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
March 2000, Zhonghua zhong liu za zhi [Chinese journal of oncology],
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
January 2004, Methods in molecular medicine,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
January 1998, Advances in experimental medicine and biology,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
February 2013, Oncogene,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
December 1999, Journal of the National Cancer Institute,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
January 2000, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
January 1991, Bioconjugate chemistry,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
July 2007, Cancer gene therapy,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
March 2000, Journal of the National Cancer Institute,
T Nishiyama, and Y Kawamura, and K Kawamoto, and H Matsumura, and N Yamamoto, and T Ito, and A Ohyama, and T Katsuragi, and T Sakai
May 2005, Acta pharmacologica Sinica,
Copied contents to your clipboard!